(107 days)
Not Found
No
The device description focuses on the physical components and materials of the electrodes and leadwire, and the performance study measures impedance, not algorithmic performance. There is no mention of AI or ML in the intended use, device description, or performance studies.
Yes
The device is described as "cutaneous electrotherapy and recording electrodes" intended for applying "electrical stimulation current to the patient's skin" for various therapeutic applications such as pain relief (TENS) and muscle stimulation (EMS, NMES, FES).
No
The device is described as an electrode for applying electrical stimulation current or recording physiological signals, primarily for therapeutic purposes like pain relief and muscle stimulation, not for diagnosing conditions.
No
The device description clearly details physical components (electrodes, leadwire, fabric, carbon mesh, hydrogel) and their materials, indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the electrodes are used to "apply electrical stimulation current to the patient's skin or record physiological signals." This involves interacting directly with the patient's body (in vivo) for therapeutic or diagnostic purposes, not for examining specimens taken from the body (in vitro).
- Device Description: The description details the physical components of the electrodes and their connection to a stimulator device, all focused on applying electrical current to the skin.
- Lack of IVD Characteristics: There is no mention of analyzing biological specimens (blood, urine, tissue, etc.), reagents, or any processes typically associated with in vitro diagnostics.
- Anatomical Site: The anatomical site is the "patient's skin," which is an in vivo application.
In summary, the device is designed for direct application to the patient's body for electrical stimulation and recording, which falls under the category of medical devices used in vivo, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The Columbia Scientific, Inc. cutaneous electrotherapy and recording electrodes are intended to be used to apply electrical stimulation current to the patient's skin or record physiological signals.
Example electrical stimulation current applications of these electrodes are:
a) Transcutaneous Electrical Nerve Stimulation (TENS) for pain relief.
b) Electrical muscle stimulation (EMS) for neck muscle stimulation
c) Functional electrical stimulation (FES).
d) Galvanic stimulation.
e) Microcurrent electrical nerve stimulation (MENS).
f) Interferential stimulation.
g) Neuromuscular electrical stimulation (NMES).
Product codes
GXY
Device Description
Single patient use cutaneous electrodes for the application of electrical stimulation are intended to be used to apply electrical stimulation current to the patient's skin or record physiological signals.
The Leadwire is attached to the electrode and is designed to be connected to a transcutaneous external muscle stimulator.
The cutaneous electrodes are single patient /multiple application use and are composed of materials commonly used in this application:
First Layer- Tricot/polyester fabric, coated with biocompatible adhesive.
Second layer- Electrically conductive Activated Carbon Mesh material.
Third layer- Biocompatible conductive Hydrogel coupling media that has been tested for biocompatibility. Test report T1262-809 NAMSA CA. Division
The electrode has one type of connection point that can be used to connect to the stimulation device (For e.g. VitalStim NMES model 5900 or 5905). The lead wire assembly is 60" with .080 inch diameter recessed female socket that is in compliance with IEC 601-1(plus amendments) and section 56.3 of 21 CFR 898.12 Performance Standard and connects to the electrode and the electrical stimulation devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
patient's skin, neck muscle
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Hospitals and Clinics
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The cutaneous electrotherapy electrode does not contain active electronics, software or firmware and is equivalent to the predicate device. The Columbia 600 electrodes are measured for effectiveness by monitoring the impedance level and comparing the level to previously approved devices. Result's of the impedance testing revealed that the subject device's impedance values were less than the other predicate devices impedance values.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.1320 Cutaneous electrode.
(a)
Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.(b)
Classification. Class II (performance standards).
0
Exhibit 2
MAY 30 2008
510 (K) Summary
Company Name: Columbia Scientific Development, LLC 420 NW 11th Ave., Suite 617 Portland, Oregon 97209
Contact: Stephen Shulman Phone: 734-663-0132 Fax: 734-663-1306 www.stevelshul(@aol.com Summary Date: April 9, 2008
Trade Name: Columbia 600 Electrode and Columbia 06 Leadwire
Common Name: Cutaneous electrode for muscle stimulation Leadwire for connection of cutaneous electrode to a battery powered muscle stimulator. Establishment Registration #: Address of manufacturer: TBD Device Class: Class II Product Code: GXY New or Modification: This notification is for a new device. Classification Name: 21 CFR 882.1320 21 CFR 898.12
Classification Panel: Neurology Predicate Device(s): 510(K) Number: K070807, Product Code: GXY Applicant: Pepin Manufacturing Inc. Trade Name: PMI Cutaneous Electrodes
1.0 Description of Electrode/Leadwire
Single patient use cutaneous electrodes for the application of electrical stimulation are intended to be used to apply electrical stimulation current to the patient's skin or record physiological signals.
The Leadwire is attached to the electrode and is designed to be connected to a transcutaneous external muscle stimulator.
The cutaneous electrodes are single patient /multiple application use and are composed of materials commonly used in this application:
First Layer- Tricot/polyester fabric, coated with biocompatible adhesive.
1
Second layer- Electrically conductive Activated Carbon Mesh material.
Third layer- Biocompatible conductive Hydrogel coupling media that has been tested for biocompatibility. Test report T1262-809 NAMSA CA. Division
The electrode has one type of connection point that can be used to connect to the stimulation device (For e.g. VitalStim NMES model 5900 or 5905). The lead wire assembly is 60" with .080 inch diameter recessed female socket that is in compliance with IEC 601-1(plus amendments) and section 56.3 of 21 CFR 898.12 Performance Standard and connects to the electrode and the electrical stimulation devices.
2.0 Indication for Use of Electrode/Leadwire
The Columbia Scientific. Inc. cutaneous electrotherapy and recording electrodes are intended to be used to apply electrical stimulation current to the patient's skin or record physiological signals.
Example electrical stimulation current applications of these electrodes are:
- a) Transcutaneous Electrical Nerve Stimulation (TENS) for pain relief.
- b) Electrical muscle stimulation (EMS) for neck muscle stimulation
- c) Functional electrical stimulation (FES).
- d) Galvanic stimulation.
- e) Microcurrent electrical nerve stimulation (MENS).
- f) Interferential stimulation.
- g) Neuromuscular electrical stimulation (NMES).
3.0 Substantial Equivalence Comparison
The cutaneous electrotherapy electrode does not contain active electronics, software or firmware and is equivalent to the predicate device. The Columbia 600 electrodes are measured for effectiveness by monitoring the impedance level and comparing the level to previously approved devices. Result's of the impedance testing revealed that the subject device's impedance values were less than the other predicate devices impedance values.
| Comparison Areas | Pepin (K070807) | "Columbia 600 Electrode
&Columbia 06 Leadwire |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------|
| Indications for use | The Pepin Manufacturing Inc.
cutaneous electrotherapy and
recording electrodes are
intended to be used to apply electrical
stimulation current to the patient's skin
or record physiological signals. | SAME |
2
| Where used | Hospitals and Clinics | SAME |
|---|---|---|
| Basic features | ||
| Size, adhesive, | ||
| packaging | 25 mm diameter, non sterile, | |
| single patient use, self adhesive, 4 | ||
| electrodes in sealed pouch. | SAME | |
| Standard met | Conformance to 21CFR 898.12 | |
| standard. | SAME |
5. Conclusion
For the above reason's, the Columbia 600 Electrode and Columbia 06 Leadwire are considered to be as safe and effective as the predicate devices and do not pose new questions of safety and effectiveness.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" are arranged in a circular pattern around the eagle. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Columbia Scientific Development, LLC % Regulatory Technology Services, LLC Mr. Mark Job Responsible Third Party Official 1394 25th Street, Northwest Buffalo, Minnesota 55313
MAY 3 0 2008
Re: K080386
Trade/Device Name: Columbia 600 Electrode and Columbia 06 Leadwire Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous electrode Regulatory Class: II Product Code: GXY Dated: May 15, 2008 Received: May 16, 2008
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
4
Page 2 - Mr. Mark Job
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark M. Millman
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known):
Device Name: Columbia 600 Electrode and Columbia 06 Leadwire
The Columbia Scientific, Inc. cutaneous electrotherapy and recording electrodes are intended to be used to apply electrical stimulation current to the patient's skin or record physiological signals.
Example electrical stimulation current applications of these electrodes are:
- a) Transcutaneous Electrical Nerve Stimulation (TENS) for pain relief.
- b) Electrical muscle stimulation (EMS) for neck muscle stimulation
- c) Functional electrical stimulation (FES).
d) Galvanic stimulation.
- e) Microcurrent electrical nerve stimulation (MENS).
- f) Interferential stimulation.
- g) Neuromuscular electrical stimulation (NMES).
| Prescription Use | X |
|---|---|
| (Part 21 CFR 801 Subpart D) |
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
| (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF |
|---|
| NEEDED) |
Concurrence of CDRH, Office of Device Evaluation(QDE)
(Division Sign-Off)
Division of General, Restorative, and Neurological Devices
510(k) Number L080381